Background Image
Table of Contents Table of Contents
Previous Page  370 / 658 Next Page
Information
Show Menu
Previous Page 370 / 658 Next Page
Page Background

4

Direct Analysis using Paper-Spray Mass Spectrometry: Method Development for the Rapid Screening of Drugs of Abuse for Forensic Toxicology

lia, Inc., IN) showing,

hanism for dispensing

ple deposition and DBS-

ectrometer inlet.

Results

Screening for drugs of abuse: resolving power, accurate mass for compound

identification

• Figure 2 shows that high and ultrahigh resolving powers (70,000 and 140,000 FWHM

FIGURE 4. Accurate mas

at m/z 200) showing drug

analyzed from DBS.

meth-

at

m/z

200) are required when evaluating samples from complex matrices with no

sample preparation and no prior chromatographic separation. Mass accuracies 1-2

ppm at the higher resolving powers (70,000 and 140,000, FWHM at m/z 200).

• Results from TraceFinder software, which is effectively used for targeted or unknown

screening analysis, are neatly summarized in Figure 3. All six drugs are positively

40

60

80

100

136.1125

40

60

80

100

150.1282

150.1313

0 ng/mL

amphetamine ampheta

identified from a dry blood spot sample.

Screening for drugs of abuse at various concentrations

• A drug mixture of six compounds was analyzed at 100, 500, 1000 and 2500 ng/mL for

forensic toxicology screening Amphetamine methamphetamine cocaine

60

80

100

0

20

136.1222

136.1125

60

80

100

bundance

0

20

150.1212

150.1282

250

0 ng/mL

.

,

,

,

cocaethylene, codeine and PCP are shown in this work.

• This group of samples were detected by full scan MS down to 100 ng/mL levels (Figure

4) (140,000 resolving power; FWHM at m/z 200).

60

80

100

0

20

40

136.1222

136.1247

136.1125

60

80

100

0

20

40

Relative A

150.1211

150.1282

100

ng/mL

Fragmentation and isotopic pattern matching for compound confirmation

• Accurate mass m/z values were used for identification of screened drugs. Isotopic

pattern matching and two fragments from the AIF experiment were used for drug

confirmation (TraceFinder table Fig. 3). Alternatively, DD MS/MS from a Q Exactive

mass spectrometer can be used.

60

80

100

0

20

40

136.1222

136.1247

136.1154

136.1125

60

80

100

0

20

40

150.1211

150.1130

150.0996

150.1211

150.1130

150.1282

500

ng/mL

• Figure 5 shows accurate mass fragmentation spectra by targeted DD MS/MS for a

DBS sample containing a mixture of 6 drugs. DD MS/MS is acquired at ultra high

resolution for enhanced signal to noise. Please note that at the higher resolution, the

signal to noise is exceptional thus allowing much lower limits of detection than

demonstrated.

136.11

136.12

136.13

m/z

0

20

40

136.1206

136.1246

150.10

150.12

150.1

m/z

0

20

40

150.0999

150.136

100

Quantitation

• Amitriptyline-spiked in blood (10–5,000 ng/mL) yielded limits of quantitation (LOQ) of

25 ng/mL using amitriptyline-

d

3

as internal standard (Figure 6).

FIGURE 5. DD MS/MS fr

(FWHM at m/z 200) in th

signal to noise ratio (as

shown) is observed. Ac

and 1-3 ppm, respective

lving powers,

e.g.

, 70,000 and

tification of drugs from DBS

h six drugs, four drugs shown

and 140 000 top to bottom

• Variability in terms of %RSD (Std Dev/Mean*100) is between <1 to 16% for drug in

blood. Figure 6 displays amitriptyline data for dried blood spots.

FIGURE 3. TraceFinder 3.0 software results shown below. Data processed in

targeted screening analysis mode. All analytes in the mix are positively

id tifi d b

t /

l

d fi

d b i t i

tt

d th

screening applications.

Sample: mixture of six

Concentrations noted in

a)

Amphetamine

,

.

curacies 1-2 ppm.

en e y exac m z va ues an con rme y so op c pa ern an e

presence of two fragments from the AIF experiment (see Table).

Data collected with the Exactive Plus mass spectrometer.

60

100 91.0544

119.0858

1000 ng/mL

.1592

300.2911

318.1711

318.1964

318 1391

deine

cocaethylene

20

60

100

20

91.0544

119.0858

500 ng/mL

300.2190

.1614

300.1810

300.2907

300 2186

.

318.2667

318.1716

318.1916

90

100 110 120

0

20

60

100

91.0543

119.0857

100 ng/mL

60

100 86.0966

159.1173

91 0545

.

.1606

300.2912

300.1794

3

318.1432

318.2648

318.1715

318.1414 318 2840

318.2286

Isotopic pattern match

Simulation

c)

PCP

100

20

60

100

20

.

86.0966

159.1172

91.0544

300.2 300.3

.1608

300.2910

300.2185

1

300.3274

318.1 318.2 318.3

.

318.1711

318.1417318.1907318.2836

Experimental

500

0

20

60

100

104.1071

86.0966

159.1172

95.0857 135.1171

m/z

m/z

100

100

150

20